Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Chinese CDMO (Stock Code: 603456.SH) specializing in small molecule and peptide API development and manufacturing. Founded 1998, headquartered in Taizhou, Zhejiang. Dedicated peptide platform offering one-stop CDMO services from preclinical research to commercial manufacturing of peptide and conjugated APIs. GMP peptide workshop in Suzhou with production capacity of 3 kg/batch and 70-90 kg/year of peptide APIs. Raybow production base for highly potent drug conjugates with OEB 4/5 GMP production. Expertise in SPPS, LPPS, hybrid phase, and tag-assisted peptide synthesis.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is listed as a cdmo in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.